AI led programme identifies influenza drug targets | 29-Jun-2023 | 07:00 | RNS |
Oral Vaccine Programme Moves Forward | 22-Jun-2023 | 07:00 | RNS |
Board Appointment | 24-May-2023 | 07:00 | RNS |
Results of Annual General Meeting | 11-May-2023 | 14:27 | RNS |
Annual Report & AGM Notice | 12-Apr-2023 | 07:00 | RNS |
Results for the year ended 31 December 2022 | 30-Mar-2023 | 07:00 | RNS |
Notification of Major Holdings | 10-Mar-2023 | 07:00 | RNS |
Notification of Major Holdings | 09-Mar-2023 | 15:51 | RNS |
Second Price Monitoring Extn | 02-Mar-2023 | 11:05 | RNS |
Price Monitoring Extension | 02-Mar-2023 | 11:00 | RNS |
Positive Results POLB001 LPS Human Challenge Trial | 02-Mar-2023 | 07:00 | RNS |
Strategic expansion of POLB 001 into oncology | 16-Jan-2023 | 07:00 | RNS |
Second Price Monitoring Extn | 09-Jan-2023 | 09:05 | RNS |
Price Monitoring Extension | 09-Jan-2023 | 09:00 | RNS |
Positive Initial Data Analysis in POLB 001 Trial | 09-Jan-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 11.20p |
Change Today | -0.60p |
% Change | -5.08 % |
52 Week High | 11.80 |
52 Week Low | 6.55 |
Volume | 2,612,011 |
Shares Issued | 500.00m |
Market Cap | £56.00m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:06 | 1,000,000 @ 11.23p |
16:35 | 31,390 @ 11.20p |
16:35 | 140 @ 11.20p |
16:35 | 139 @ 11.20p |
16:35 | 1 @ 11.20p |
CEO | Jeremy Skillington |
CFO | Ian O’Connel |
You are here: research